EFSA Provision of documents
Rapporteur Member State assessment reports submitted for the EU peer review of active substances used in plant protection products (published before March 2015)

In compliance with relevant legislative framework (see footnote), EFSA provides access to the documentation of the risk assessment submitted by a respective rapporteur Member State for the EU peer review, of existing and new active substances used in plant protection products. In accordance with relevant legislation, confidential information has been removed from the assessment reports upon justified request of the respective applicant(s). A guidance document regarding information eligible for removal is available.

To obtain an assessment report, please click on the active substance name. A duly completed online request form needs to be submitted in order to receive an email providing access to the respective documentation.

For draft assessment reports (DARs) and renewal assessment reports (RARs) prepared by Member States after March 2015, please check the Consultations page on EFSA website


Assessment reports available:
Active substance Existing or new active substance Rapporteur Member State Document type Publication date
Diuron
Existing (2nd stage)
DK
Draft Assessment Report
29/07/2005
Trifluralin
Existing (2nd stage)
EL
Draft Assessment Report
29/07/2005
Tolylfluanid
Existing (2nd stage)
FI
Draft Assessment Report
29/07/2005
Oxamyl
Existing (2nd stage)
IE
Draft Assessment Report
29/07/2005
Glufosinate
Existing (2nd stage)
SE
Draft Assessment Report
29/07/2005
Tribenuron
Existing (2nd stage)
SE
Draft Assessment Report
29/07/2005
1-Methylcyclopropene
New
UK
Draft Assessment Report
29/07/2005
Triticonazole
Existing (2nd stage)
AT
Draft Assessment Report
01/08/2005
Rimsulfuron
Existing (2nd stage)
DE
Draft Assessment Report
01/08/2005
Clodinafop
Existing (2nd stage)
NL
Draft Assessment Report
01/08/2005
Tolclofos-methyl
Existing (2nd stage)
SE
Draft Assessment Report
01/08/2005
Pirimicarb
Existing (2nd stage)
UK
Draft Assessment Report
01/08/2005
Pirimiphos-methyl
Existing (2nd stage)
UK
Draft Assessment Report
01/08/2005
Dimethenamid
Existing (2nd stage)
DE
Draft Assessment Report
02/08/2005
Dichlorprop-p
Existing (2nd stage)
DK
Draft Assessment Report
02/08/2005
Clopyralid
Existing (2nd stage)
FI
Draft Assessment Report
02/08/2005
Malathion
Existing (2nd stage)
FI
Draft Assessment Report
02/08/2005
Cyprodinil
Existing (2nd stage)
FR
Draft Assessment Report
02/08/2005
Fosetyl-Al
Existing (2nd stage)
FR
Draft Assessment Report
02/08/2005
Triclopyr
Existing (2nd stage)
IE
Draft Assessment Report
02/08/2005
Trinexapac
Existing (2nd stage)
NL
Draft Assessment Report
02/08/2005
Fenitrothion
Existing (2nd stage)
UK
Draft Assessment Report
02/08/2005
Thiodicarb
Existing (2nd stage)
UK
Draft Assessment Report
02/08/2005
Phosalone
Existing (2nd stage)
AT
Draft Assessment Report
03/08/2005
Pyrimethanil
Existing (2nd stage)
AT
Draft Assessment Report
03/08/2005
Metconazole
Existing (2nd stage)
BE
Draft Assessment Report
03/08/2005
Haloxyfop-P
Existing (2nd stage)
DK
Draft Assessment Report
03/08/2005
1,3-Dichloropropene
Existing (2nd stage)
ES
Draft Assessment Report
03/08/2005
Captan
Existing (2nd stage)
IT
Draft Assessment Report
03/08/2005
Folpet
Existing (2nd stage)
IT
Draft Assessment Report
03/08/2005
Fenamiphos
Existing (2nd stage)
NL
Draft Assessment Report
03/08/2005
Ethoprophos
Existing (2nd stage)
UK
Draft Assessment Report
03/08/2005
Dimethomorph
Existing (2nd stage)
DE
Draft Assessment Report
11/08/2005
Fipronil
Existing (2nd stage)
FR
Draft Assessment Report
11/08/2005
Dichlorvos
Existing (2nd stage)
IT
Draft Assessment Report
11/08/2005
Formetanate
Existing (2nd stage)
IT
Draft Assessment Report
11/08/2005
Ethephon
Existing (2nd stage)
NL
Draft Assessment Report
11/08/2005
Methiocarb
Existing (2nd stage)
UK
Draft Assessment Report
11/08/2005
Benfuracarb
Existing (2nd stage)
BE
Draft Assessment Report
16/09/2005
Carbofuran
Existing (2nd stage)
BE
Draft Assessment Report
16/09/2005
Carbosulfan
Existing (2nd stage)
BE
Draft Assessment Report
16/09/2005
Metribuzin
Existing (2nd stage)
DE
Draft Assessment Report
16/09/2005
Carbaryl
Existing (2nd stage)
ES
Draft Assessment Report
16/09/2005
Trichlorfon
Existing (2nd stage)
ES
Draft Assessment Report
16/09/2005
Oxydemethon-methyl
Existing (2nd stage)
FR
Draft Assessment Report
16/09/2005
Propamocarb
Existing (2nd stage)
IE
Draft Assessment Report
16/09/2005
Dimethoate
Existing (2nd stage)
UK
Draft Assessment Report
16/09/2005
Fluoxastrobin
New
UK
Draft Assessment Report
16/09/2005
Methomyl
Existing (2nd stage)
UK
Draft Assessment Report
16/09/2005
Dimoxystrobin
New
UK
Draft Assessment Report
27/09/2005
Phosmet
Existing (2nd stage)
ES
Draft Assessment Report
28/10/2005
Diazinon
Existing (2nd stage)
PT
Draft Assessment Report
01/02/2006
Metrafenone
New
UK
Draft Assessment Report
01/02/2006
Cadusafos
Existing (2nd stage)
EL
Draft Assessment Report
09/02/2006
Fenoxaprop-P
Existing (3rd stage)
AT
Draft Assessment Report
26/04/2006
Bifenox
Existing (3rd stage)
BE
Draft Assessment Report
26/04/2006
Epoxiconazole
Existing (3rd stage)
DE
Draft Assessment Report
26/04/2006
Imidacloprid
Existing (3rd stage)
DE
Draft Assessment Report
26/04/2006
Fludioxonil
Existing (3rd stage)
DK
Draft Assessment Report
26/04/2006
Fluquinconazole
Existing (3rd stage)
IE
Draft Assessment Report
26/04/2006
Diflubenzuron
Existing (3rd stage)
SE
Draft Assessment Report
26/04/2006
Prosulfocarb
Existing (3rd stage)
SE
Draft Assessment Report
26/04/2006
Quinoclamin
Existing (3rd stage)
SE
Draft Assessment Report
26/04/2006
Fuberidazole
Existing (3rd stage)
UK
Draft Assessment Report
26/04/2006
Mepiquat
Existing (3rd stage)
UK
Draft Assessment Report
26/04/2006
Amidosulfuron
Existing (3rd stage)
AT
Draft Assessment Report
04/05/2006
Napropamide
Existing (3rd stage)
DK
Draft Assessment Report
04/05/2006
Buprofezin
Existing (3rd stage)
FI
Draft Assessment Report
04/05/2006
Clofentezine
Existing (3rd stage)
UK
Draft Assessment Report
04/05/2006
Clomazone
Existing (3rd stage)
DK
Draft Assessment Report
05/05/2006
Chloridazon
Existing (3rd stage)
DE
Draft Assessment Report
10/05/2006
Fenpropimorph
Existing (3rd stage)
DE
Draft Assessment Report
10/05/2006
Bitertanol
Existing (3rd stage)
UK
Draft Assessment Report
11/05/2006
Diflufenican
Existing (3rd stage)
UK
Draft Assessment Report
11/05/2006
Tralkoxydim
Existing (3rd stage)
UK
Draft Assessment Report
15/05/2006
Fluopicolide
New
UK
Draft Assessment Report
17/05/2006
Myclobutanil
Existing (3rd stage)
BE
Draft Assessment Report
31/05/2006
Fenpropidin
Existing (3rd stage)
SE
Draft Assessment Report
31/05/2006
Clethodim
Existing (3rd stage)
NL
Draft Assessment Report
02/06/2006
Dicloran
Existing (3rd stage)
ES
Draft Assessment Report
13/06/2006
Flutolanil
Existing (3rd stage)
FI
Draft Assessment Report
13/06/2006
Chloropicrin
Existing (3rd stage)
IT
Draft Assessment Report
13/06/2006
Dimethipin
Existing (3rd stage)
EL
Draft Assessment Report
14/06/2006
Tebufenozide
Existing (3rd stage)
DE
Draft Assessment Report
15/06/2006
Fenpyroximate
Existing (3rd stage)
DE
Draft Assessment Report
03/07/2006
Propaquizafop
Existing (3rd stage)
IT
Draft Assessment Report
03/07/2006
Cyflufenamid
New
UK
Draft Assessment Report
03/07/2006
Nicosulfuron
Existing (3rd stage)
UK
Draft Assessment Report
03/07/2006
Thiobencarb
Existing (3rd stage)
ES
Draft Assessment Report
05/07/2006
Pencycuron
Existing (3rd stage)
NL
Draft Assessment Report
06/07/2006
Methyl bromide
Existing (3rd stage)
UK
Draft Assessment Report
06/07/2006
Benfluralin
Existing (3rd stage)
BE
Draft Assessment Report
17/07/2006
Hexythiazox
Existing (3rd stage)
FI
Draft Assessment Report
17/07/2006
Abamectin
Existing (3rd stage)
NL
Draft Assessment Report
17/07/2006
Cyanamide
Existing (3rd stage)
DE
Draft Assessment Report
18/07/2006
Fenbuconazole
Existing (3rd stage)
UK
Draft Assessment Report
18/07/2006
Bifenthrin
Existing (3rd stage)
FR
Draft Assessment Report
19/07/2006
Triflumizole
Existing (3rd stage)
NL
Draft Assessment Report
19/07/2006
Bromuconazole
Existing (3rd stage)
BE
Draft Assessment Report
20/07/2006
Fenazaquin
Existing (3rd stage)
EL
Draft Assessment Report
21/07/2006
Carbetamide
Existing (3rd stage)
FR
Draft Assessment Report
31/07/2006
Proquinazid
New
UK
Draft Assessment Report
31/07/2006
Fluazinam
Existing (3rd stage)
AT
Draft Assessment Report
01/08/2006
Pinoxaden
New
UK
Draft Assessment Report
04/08/2006
Triadimenol
Existing (3rd stage)
UK
Draft Assessment Report
09/08/2006
Butralin
Existing (3rd stage)
FR
Draft Assessment Report
12/08/2006
Pyriproxifen
Existing (3rd stage)
NL
Draft Assessment Report
05/09/2006
Asulam
Existing (3rd stage)
UK
Draft Assessment Report
05/09/2006
Carboxin
Existing (3rd stage)
UK
Draft Assessment Report
05/09/2006
Sulcotrione
Existing (3rd stage)
DE
Draft Assessment Report
12/12/2006
Cyproconazole
Existing (3rd stage)
IE
Draft Assessment Report
12/12/2006
Zeta-cypermethrin
Existing (3rd stage)
BE
Draft Assessment Report
13/12/2006
Metaldehyde
Existing (3rd stage)
AT
Draft Assessment Report
09/02/2007
Paclobutrazol
Existing (3rd stage)
UK
Draft Assessment Report
12/03/2007
Aclonifen
Existing (3rd stage)
DE
Draft Assessment Report
08/05/2007
Bensulfuron
Existing (3rd stage)
IT
Draft Assessment Report
08/05/2007
Isoxaben
Existing (3rd stage)
SE
Draft Assessment Report
08/05/2007
Metazachlor
Existing (3rd stage)
UK
Draft Assessment Report
31/05/2007
Dithianon
Existing (3rd stage)
EL
Draft Assessment Report
19/06/2007
Flurochloridone
Existing (3rd stage)
ES
Draft Assessment Report
19/06/2007
Dodine
Existing (3rd stage)
PT
Draft Assessment Report
19/06/2007
Tetraconazole
Existing (3rd stage)
IT
Draft Assessment Report
25/06/2007
Tefluthrin
Existing (3rd stage)
DE
Draft Assessment Report
17/07/2007
Spirodiclofen
New
NL
Draft Assessment Report
17/07/2007
Spiromesifen
New
UK
Draft Assessment Report
17/07/2007
Paecilomyces lilacinus strain 251
New
BE
Draft Assessment Report
19/07/2007
Cycloxydim
Existing (3rd stage)
AT
Draft Assessment Report
24/07/2007
Difenconazole
Existing (3rd stage)
SE
Draft Assessment Report
24/07/2007
Benthiavalicarb
New
BE
Draft Assessment Report
26/07/2007
Prothioconazole
New
UK
Draft Assessment Report
27/07/2007
Triflumuron
Existing (3rd stage)
IT
Draft Assessment Report
06/08/2007
Dodemorph
Existing (3rd stage)
NL
Draft Assessment Report
06/08/2007
Dimethachlor
Existing (3rd stage)
DE
Draft Assessment Report
07/08/2007
Tau-fluvalinate
Existing (3rd stage)
DK
Draft Assessment Report
03/09/2007
Prochloraz
Existing (3rd stage)
IE
Draft Assessment Report
03/09/2007
Etofenprox
Existing (3rd stage)
IT
Draft Assessment Report
03/09/2007
Pyridaben
Existing (3rd stage)
NL
Draft Assessment Report
03/09/2007
Fenbutatin-oxide
Existing (3rd stage)
BE
Draft Assessment Report
06/09/2007
Etridiazole
Existing (3rd stage)
NL
Draft Assessment Report
06/09/2007
Lufenuron
Existing (3rd stage)
PT
Draft Assessment Report
06/09/2007
Quinmerac
Existing (3rd stage)
UK
Draft Assessment Report
06/09/2007
Topramezone
New
FR
Draft Assessment Report
11/09/2007
Bupirimate
Existing (3rd stage)
NL
Draft Assessment Report
19/09/2007
Metosulam
Existing (3rd stage)
FR
Draft Assessment Report
26/09/2007
Triflusulfuron
Existing (3rd stage)
FR
Draft Assessment Report
26/09/2007
Fluometuron
Existing (3rd stage)
EL
Draft Assessment Report
16/10/2007
Fluazifop-P-butyl
Existing (3rd stage)
FR
Draft Assessment Report
16/10/2007
Oryzalin
Existing (3rd stage)
FR
Draft Assessment Report
16/10/2007
Picloram
Existing (3rd stage)
UK
Draft Assessment Report
16/10/2007
Metam
Existing (3rd stage)
BE
Draft Assessment Report
24/10/2007
Calcium phosphide
Existing (3rd stage)
DE
Draft Assessment Report
25/10/2007
Dichlorobenzoic acid methylester
Existing (3rd stage)
DE
Draft Assessment Report
07/11/2007
Cyromazine
Existing (3rd stage)
EL
Draft Assessment Report
07/11/2007
Ethalfluralin
Existing (3rd stage)
EL
Draft Assessment Report
07/11/2007
Oxyfluorfen
Existing (3rd stage)
ES
Draft Assessment Report
07/11/2007
Flurpirimidole
Existing (3rd stage)
FI
Draft Assessment Report
07/11/2007
Propargite
Existing (3rd stage)
FR
Draft Assessment Report
07/11/2007
Tricyclazole
Existing (3rd stage)
FR
Draft Assessment Report
07/11/2007
Oxadiazon
Existing (3rd stage)
IT
Draft Assessment Report
07/11/2007
Fenoxycarb
Existing (3rd stage)
NL
Draft Assessment Report
07/11/2007
Cymoxanil
Existing (3rd stage)
AT
Draft Assessment Report
13/11/2007
Penconazole
Existing (3rd stage)
DE
Draft Assessment Report
13/11/2007
Teflubenzuron
Existing (3rd stage)
UK
Draft Assessment Report
13/11/2007
Dazomet
Existing (3rd stage)
BE
Draft Assessment Report
27/11/2007
Sodium nitrocompounds
Existing (3rd stage)
EL
Draft Assessment Report
30/11/2007
Diphenylamine
Existing (3rd stage)
IE
Draft Assessment Report
30/11/2007
Aluminum phosphide
Existing (3rd stage)
DE
Draft Assessment Report
07/12/2007
Magnesium phosphide
Existing (3rd stage)
DE
Draft Assessment Report
07/12/2007
Quizalofop-P-ethyl
Existing (3rd stage)
FI
Draft Assessment Report
07/12/2007
Quizalofop-P-tefuryl
Existing (3rd stage)
FI
Draft Assessment Report
07/12/2007
Triazoxide
Existing (3rd stage)
UK
Draft Assessment Report
07/12/2007
Chlorsulfuron
Existing (3rd stage)
EL
Draft Assessment Report
12/12/2007
Chlormequat
Existing (3rd stage)
UK
Draft Assessment Report
12/12/2007
Metamitron
Existing (3rd stage)
UK
Draft Assessment Report
12/12/2007
Tebuconazole
Existing (3rd stage)
DK
Draft Assessment Report
19/12/2007
Lenacil
Existing (3rd stage)
BE
Draft Assessment Report
16/01/2008
Copper compounds
Existing (3rd stage)
FR
Draft Assessment Report
16/01/2008
Aminopyralid
New
UK
Draft Assessment Report
16/01/2008
Chlorate
Existing (3rd stage)
FR
Draft Assessment Report
17/01/2008
Mandipropamid
New
AT
Draft Assessment Report
28/01/2008
Tri-allate
Existing (3rd stage)
UK
Draft Assessment Report
28/01/2008
Tebufenpyrad
Existing (3rd stage)
DE
Draft Assessment Report
05/02/2008
Acequinocyl
New
NL
Draft Assessment Report
11/02/2008
Tembotrione
New
AT
Draft Assessment Report
13/02/2008
Novaluron
New
UK
Draft Assessment Report
13/02/2008
Imazaquin
Existing (3rd stage)
BE
Draft Assessment Report
27/02/2008
Dicamba
Existing (3rd stage)
DK
Draft Assessment Report
27/02/2008
Paraffin oil CAS 8042-47-5 - Neudorff
Existing (4th stage)
EL
Draft Assessment Report
08/09/2008
Paraffin oil CAS 8042-47-5 - Staehler
Existing (4th stage)
EL
Draft Assessment Report
08/09/2008
Paraffin oils CAS 64742-46-7, CAS 72623-86-0, CAS 97862-82-3
Existing (4th stage)
EL
Draft Assessment Report
08/09/2008
2-phenylphenol
Existing (4th stage)
ES
Draft Assessment Report
08/09/2008
Difenacoum
Existing (4th stage)
FI
Draft Assessment Report
08/09/2008
Sulphur
Existing (4th stage)
FR
Draft Assessment Report
08/09/2008
Etofenprox
Existing (3rd stage)
IT
Draft Assessment Report
08/09/2008
Ethanol
Existing (4th stage)
UK
Draft Assessment Report
08/09/2008
Benfuracarb
Re-submission
BE
Additional Report
20/10/2008
Methomyl
Re-submission
UK
Additional Report
20/10/2008
1,4-diaminobutane (Putrescine)
Existing (4th stage)
AT
Draft Assessment Report
04/11/2008
Quartz sand
Existing (4th stage)
AT
Draft Assessment Report
04/11/2008
Straight Chain Lepidopteran Pheromones
Existing (4th stage)
AT
Draft Assessment Report
04/11/2008
Blood meal
Existing (4th stage)
BE
Draft Assessment Report
04/11/2008
Bone oil
Existing (4th stage)
BE
Draft Assessment Report
04/11/2008
Methyl nonyl ketone
Existing (4th stage)
BE
Draft Assessment Report
04/11/2008
Trimethylamine hydrochloride
Existing (4th stage)
BE
Draft Assessment Report
04/11/2008
Fat distillation residues
Existing (4th stage)
CZ
Draft Assessment Report
04/11/2008
Beauveria bassiana ATCC-74040
Existing (4th stage)
DE
Draft Assessment Report
04/11/2008
Beauveria bassiana GHA
Existing (4th stage)
DE
Draft Assessment Report
04/11/2008
Cydia pomonella GV
Existing (4th stage)
DE
Draft Assessment Report
04/11/2008
Bacillus thuringiensis kurstaki ABTS-351
Existing (4th stage)
DK
Draft Assessment Report
04/11/2008
Bacillus thuringiensis kurstaki PB-54
Existing (4th stage)
DK
Draft Assessment Report
04/11/2008
Bacillus thuringiensis kurstaki SA-11,SA-12,EG-2348
Existing (4th stage)
DK
Draft Assessment Report
04/11/2008
Streptomyces griseoviridis K-61
Existing (4th stage)
EE
Draft Assessment Report
04/11/2008
Fish oil
Existing (4th stage)
EL
Draft Assessment Report
04/11/2008
Hydrolised proteins
Existing (4th stage)
EL
Draft Assessment Report
04/11/2008
Kieselgur (Diatomaceous earth)
Existing (4th stage)
EL
Draft Assessment Report
04/11/2008
Paraffin oil CAS-64742-54-7
Existing (4th stage)
EL
Draft Assessment Report
04/11/2008
Sheep fat
Existing (4th stage)
EL
Draft Assessment Report
04/11/2008
Tall oil crude CAS 8002-26-4
Existing (4th stage)
EL
Draft Assessment Report
04/11/2008
Tall oil pitch CAS-8016-81-7
Existing (4th stage)
EL
Draft Assessment Report
04/11/2008
Urea
Existing (4th stage)
EL
Draft Assessment Report
04/11/2008
Calcium carbonate
Existing (4th stage)
ES
Draft Assessment Report
04/11/2008
Rapeseed oil
Existing (4th stage)
ES
Draft Assessment Report
04/11/2008
Trichoderma viride ICC-080, T-25, TV-1
Existing (4th stage)
FR
Draft Assessment Report
04/11/2008
Aluminium silicate (Kaolin)
Existing (4th stage)
HU
Draft Assessment Report
04/11/2008
Sodium aluminium silicate
Existing (4th stage)
HU
Draft Assessment Report
04/11/2008
Fatty acids
Existing (4th stage)
IE
Draft Assessment Report
04/11/2008
Bacillus thuringiensis aizawai ABTS-1857
Existing (4th stage)
IT
Draft Assessment Report
04/11/2008
Bacillus thuringiensis aizawai GC-91
Existing (4th stage)
IT
Draft Assessment Report
04/11/2008
Bacillus thuringiensis israelensis AM-6552
Existing (4th stage)
IT
Draft Assessment Report
04/11/2008
Bacillus thuringiensis tenebrionis NB-176
Existing (4th stage)
IT
Draft Assessment Report
04/11/2008
Carbon monoxide
Existing (4th stage)
IT
Draft Assessment Report
04/11/2008
Pyrethrins
Existing (4th stage)
IT
Draft Assessment Report
04/11/2008
Lecanicillium muscarium (Verticillium lecanil)
Existing (4th stage)
NL
Draft Assessment Report
04/11/2008
Metarhizium anisopliae
Existing (4th stage)
NL
Draft Assessment Report
04/11/2008
Vetricillium albo-atrum (Vetricillium dahliae)
Existing (4th stage)
NL
Draft Assessment Report
04/11/2008
Garlic extract
Existing (4th stage)
PL
Draft Assessment Report
04/11/2008
Aluminium ammonium sulfate
Existing (4th stage)
PT
Draft Assessment Report
04/11/2008
Ammonium acetate
Existing (4th stage)
PT
Draft Assessment Report
04/11/2008
Calcium carbide
Existing (4th stage)
PT
Draft Assessment Report
04/11/2008
Denatonium benzoate
Existing (4th stage)
PT
Draft Assessment Report
04/11/2008
Pythium oligandrum
Existing (4th stage)
SE
Draft Assessment Report
04/11/2008
Trichoderma atroviride IMI-206040
Existing (4th stage)
SE
Draft Assessment Report
04/11/2008
Trichoderma harzianum Rifai
Existing (4th stage)
SE
Draft Assessment Report
04/11/2008
Trichoderma polysporum IMI-206039
Existing (4th stage)
SE
Draft Assessment Report
04/11/2008
Nicotine
Existing (4th stage)
UK
Draft Assessment Report
04/11/2008
Pepper dust
Existing (4th stage)
UK
Draft Assessment Report
04/11/2008
Cadusafos
Re-submission
EL
Additional Report
14/01/2009
Sodium hypochlorite
Existing (4th stage)
NL
Draft Assessment Report
09/02/2009
Carbon dioxide
Existing (4th stage)
UK
Draft Assessment Report
09/02/2009
Terbuthylazine
Existing (3rd stage)
UK
Draft Assessment Report
09/02/2009
Trifluralin
Re-submission
EL
Additional Report
20/02/2009
Malathion
Re-submission
UK
Additional Report
02/03/2009
Carbofuran
Re-submission
BE
Additional Report
04/03/2009
Paecilomyces fumosoroseus
New
BE
Draft Assessment Report
04/03/2009
Adoxophyes orana granulovirus
New
DE
Draft Assessment Report
04/03/2009
Flonicamid
New
FR
Draft Assessment Report
09/03/2009
Heptamaloxyloglucan
New
FR
Draft Assessment Report
09/03/2009
Potassium iodide
New
NL
Draft Assessment Report
09/03/2009
Potassium thiocyanate
New
NL
Draft Assessment Report
09/03/2009
Meptyldinocap
New
UK
Draft Assessment Report
09/03/2009
Phlebiopsis gigantea
Existing (4th stage)
EE
Draft Assessment Report
16/03/2009
Triflumizole
Re-submission
NL
Additional Report
29/03/2009
Didecyldimethylammonium chloride
Existing (4th stage)
NL
Draft Assessment Report
27/04/2009
1,3-Dichloropropene
Re-submission
ES
Additional Report
15/05/2009
Haloxyfop-P
Re-submission
DK
Additional Report
26/05/2009
Bispyribac-sodium
New
IT
Draft Assessment Report
11/06/2009
Carbosulfan
Re-submission
BE
Additional Report
24/06/2009
Hymexazol
Existing (3rd stage)
FI
Draft Assessment Report
17/07/2009
Diclofop-methyl
Existing (3rd stage)
FR
Draft Assessment Report
17/07/2009
Diethofencarb
Existing (3rd stage)
FR
Draft Assessment Report
17/07/2009
Flufenoxuron
Existing (3rd stage)
FR
Draft Assessment Report
17/07/2009
Flutriafol
Existing (3rd stage)
UK
Draft Assessment Report
17/07/2009
Guazatine
Existing (3rd stage)
UK
Draft Assessment Report
17/07/2009
Napropamide
Re-submission
DK
Additional Report
28/07/2009
Quinmerac
Re-submission
UK
Additional Report
28/07/2009
Fenbuconazole
Re-submission
UK
Additional Report
31/07/2009
Pyridaben
Re-submission
NL
Additional Report
03/08/2009
Imazalil
Annex I Renewal
NL
Assessment Report
06/08/2009
Prohexadione-calcium
Annex I Renewal
FR
Assessment Report
07/08/2009
Azoxystrobin
Annex I Renewal
UK
Assessment Report
07/08/2009
Azimsulfuron
Annex I Renewal
SE
Assessment Report
11/08/2009
Metosulam
Re-submission
FR
Additional Report
19/08/2009
Diclofop-methyl
Re-submission
FR
Additional Report
31/08/2009
Dodine
Re-submission
PT
Additional Report
04/09/2009
Buprofezin
Re-submission
UK
Additional Report
23/09/2009
Oryzalin
Re-submission
FR
Additional Report
28/09/2009
Spiroxamine
Annex I Renewal
DE
Assessment Report
21/10/2009
Hymexazol
Re-submission
FI
Additional Report
28/10/2009
Tau-fluvalinate
Re-submission
DK
Additional Report
29/10/2009
Dichlobenil
Existing (3rd stage)
UK
Draft Assessment Report
03/11/2009
Dichlobenil
Re-submission
UK
Additional Report
03/11/2009
Dicloran
Re-submission
ES
Additional Report
06/11/2009
Hexythiazox
Re-submission
FI
Additional Report
06/11/2009
8-hydroxyquinoline
Re-submission
ES
Additional Report
13/11/2009
Guazatine
Re-submission
UK
Additional Report
17/11/2009
Bromuconazole (Additional Report)
Re-submission
BE
Draft Assessment Report
26/11/2009
Myclobutanil
Re-submission
BE
Additional Report
01/12/2009
Flurochloridone (additional report)
Existing (3rd stage)
ES
Additional Report
07/12/2009
Asulam
Re-submission
UK
Additional Report
09/12/2009
Zinc phosphide
Existing (4th stage)
DE
Draft Assessment Report
10/12/2009
Zinc phosphide
Re-submission
DE
Additional Report
10/12/2009
Clethodim
Re-submission
NL
Additional Report
11/12/2009
Methyl bromide
Re-submission
UK
Additional Report
14/12/2009
Pencycuron
Re-submission
NL
Additional Report
15/12/2009
Tebufenozide (Additional Report)
Existing (3rd stage)
DE
Additional Report
18/12/2009
Isoxaben
Re-submission
SE
Additional Report
19/12/2009
Fenbutatin oxide
Re-submission
BE
Additional Report
04/01/2010
Fenoxycarb
Re-submission
NL
Additional Report
04/01/2010
Bromadiolone
Existing (4th stage)
SE
Draft Assessment Report
05/01/2010
Bromadiolone
Re-submission
SE
Additional Report
05/01/2010
Bitertanol (additional report)
Existing (3rd stage)
UK
Additional Report
06/01/2010
Carboxin
Re-submission
UK
Additional Report
07/01/2010
6-benzyladenine
Existing (4th stage)
UK
Additional Report
08/01/2010
6-benzyladenine
Existing (4th stage)
UK
Draft Assessment Report
08/01/2010
Tefluthrin
Re-submission
DE
Additional Report
13/01/2010
Ethoxyquin
Re-submission
DE
Additional Report
15/01/2010
Azadirachtin
Re-submission
DE
Additional Report
19/01/2010
Azadirachtin
Existing (4th stage)
DE
Draft Assessment Report
19/01/2010
Propisochlor
Re-submission
HU
Additional Report
20/01/2010
Fluroxypyr
Annex I Renewal
IE
Assessment Report
21/01/2010
Dazomet
Re-submission
BE
Additional Report
22/01/2010
Cyanamide
Re-submission
DE
Additional Report
29/01/2010
1-Decanol
Existing (4th stage)
IT
Draft Assessment Report
02/02/2010
1-Decanol
Re-submission
UK
Additional Report
02/02/2010
Cycloxydim
Re-submission
AT
Additional Report
04/02/2010
Diethofencarb
Re-submission
FR
Additional Report
05/02/2010
Bupirimate
Re-submission
NL
Additional Report
08/02/2010
Oxyfluorfen
Re-submission
ES
Additional Report
15/02/2010
Paclobutrazol
Re-submission
UK
Additional Report
17/02/2010
Chlorthal-dimethyl
Existing (3rd stage)
EL
Draft Assessment Report
19/02/2010
Flutriafol
Re-submission
UK
Additional Report
19/02/2010
Dithianon
Re-submission
EL
Additional Report
24/02/2010
Fluometuron
Re-submission
EL
Additional Report
24/02/2010
Indolylbutyric acid
Re-submission
FR
Additional Report
24/02/2010
Indolylbutyric acid
Existing (4th stage)
FR
Draft Assessment Report
24/02/2010
Terbuthylazine
Re-submission
UK
Additional Report
26/02/2010
Fenazaquin
Re-submission
EL
Additional Report
01/03/2010
Sintofen
Existing (3rd stage)
FR
Draft Assessment Report
02/03/2010
Sintofen
Re-submission
FR
Additional Report
02/03/2010
Lime sulphur
Re-submission
ES
Additional Report
04/03/2010
Lime sulphur
Existing (4th stage)
ES
Draft Assessment Report
04/03/2010
Acrinathrin
Existing (3rd stage)
FR
Draft Assessment Report
09/03/2010
Acrinathrin
Existing (3rd stage)
FR
Additional Report
09/03/2010
Cyproconazole
Re-submission
IE
Additional Report
15/03/2010
Fluazifop-P-butyl
Re-submission
FR
Additional Report
18/03/2010
Aluminium sulfate
Re-submission
NL
Additional Report
19/03/2010
Etridiazole
Re-submission
NL
Additional Report
19/03/2010
Triflumuron
Re-submission
IT
Additional Report
22/03/2010
Propargite
Re-submission
IT
Additional Report
29/03/2010
Propanil
Existing (3rd stage)
IT
Draft Assessment Report
30/03/2010
Propanil
Re-submission
IT
Additional Report
30/03/2010
Flurprimidol
Re-submission
FI
Additional Report
06/04/2010
Penoxsulam
New
IT
Draft Assessment Report
08/04/2010
Sulfuryl fluoride
New
UK
Draft Assessment Report
08/04/2010
Chloropicrin
Re-submission
IT
Additional Report
12/04/2010
Flufenoxuron
Re-submission
FR
Additional Report
16/04/2010
Metaldehyde
Re-submission
AT
Additional Report
21/04/2010
1-naphthylacetamide
Existing (4th stage)
FR
Draft Assessment Report
23/04/2010
1-naphthylacetamide
Re-submission
FR
Additional Report
23/04/2010
1-naphthylacetic acid
Existing (4th stage)
FR
Draft Assessment Report
23/04/2010
1-naphthylacetic acid
Re-submission
FR
Additional Report
23/04/2010
Ethoxyquin
Existing (4th stage)
DE
Draft Assessment Report
24/06/2010
Carbendazim
Annex I Renewal
DE
Assessment Report
29/06/2010
2-naphthyloxyacetic acid
Existing (4th stage)
FR
Draft Assessment Report
30/06/2010
2-naphthyloxyacetic acid
Re-submission
IT
Additional Report
30/06/2010
Triazoxide
Re-submission
UK
Additional Report
01/07/2010
Acetochlor
Existing (3rd stage)
ES
Draft Assessment Report
05/07/2010
Acetochlor (additional report)
Re-submission
ES
Additional Report
05/07/2010
Fenugreek seed powder (FEN 560)
New
FR
Draft Assessment Report
08/07/2010
Kresoxim-methyl
Annex I Renewal
BE
Assessment Report
09/07/2010
Carbetamide (Additional Report)
Re-submission
FR
Additional Report
01/08/2010
Bifenthrin
Re-submission
FR
Additional Report
07/09/2010
Fluquinconazole (additional report)
Re-submission
IE
Additional Report
23/09/2010
Potassium phosphonates
New
FR
Draft Assessment Report
04/10/2010
Limestone
Existing (4th stage)
AT
Draft Assessment Report
19/10/2010
Metam
Re-submission
BE
Additional Report
20/10/2010
Diphenylamine
Re-submission
IE
Additional Report
10/02/2011
Cyflumetofen
New
NL
Draft Assessment Report
15/02/2011
Fenpyrazamine
New
AT
Draft Assessment Report
18/02/2011
Acetic acid
Existing (4th stage)
DE
Draft Assessment Report
24/02/2011
Gibberelic acid
Existing (4th stage)
HU
Draft Assessment Report
24/02/2011
Gibberellins
Existing (4th stage)
HU
Draft Assessment Report
24/02/2011
Potassium hydrogen carbonate
Existing (4th stage)
IE
Draft Assessment Report
24/02/2011
Sea-algae extract
Existing (4th stage)
IT
Draft Assessment Report
24/02/2011
Tea tree oil
Existing (4th stage)
LV
Draft Assessment Report
24/02/2011
Spearmint oil
Existing (4th stage)
SE
Draft Assessment Report
24/02/2011
Citronella oil
Existing (4th stage)
UK
Draft Assessment Report
24/02/2011
Clove oil
Existing (4th stage)
UK
Draft Assessment Report
24/02/2011
Ethylene
Existing (4th stage)
UK
Draft Assessment Report
24/02/2011
Iron sulphate
Existing (4th stage)
UK
Draft Assessment Report
24/02/2011
Phosphane
New
DE
Draft Assessment Report
28/02/2011
BAS 700 F (fluxapyroxad)
New
UK
Draft Assessment Report
28/02/2011
Prochloraz
Re-submission
IE
Additional Report
16/03/2011
Isopyrazam
New
UK
Draft Assessment Report
08/04/2011
Trichoderma asperellum strain T34
New
UK
Draft Assessment Report
28/06/2011
Trichoderma atroviride I-1237
New
FR
Draft Assessment Report
07/07/2011
Sedaxane
New
FR
Draft Assessment Report
25/07/2011
Eugenol
New
UK
Draft Assessment Report
01/08/2011
Geraniol
New
UK
Draft Assessment Report
01/08/2011
Thymol
New
UK
Draft Assessment Report
01/08/2011
Bacillus firmus
New
FR
Draft Assessment Report
02/09/2011
Bixafen
New
UK
Draft Assessment Report
14/10/2011
Fluopyram
New
DE
Draft Assessment Report
20/10/2011
Penflufen
New
UK
Draft Assessment Report
26/10/2011
Spodoptera littoralis nucleopolyhedrovirus
New
EE
Draft Assessment Report
27/10/2011
BAS 650 F
New
NL
Draft Assessment Report
27/10/2011
Helicoverpa armigera nucleopolyhedrovirus
New
EE
Draft Assessment Report
28/10/2011
Halosulfuron-methyl
New
IT
Draft Assessment Report
28/10/2011
Ascorbic acid
New
NL
Draft Assessment Report
24/11/2011
Pseudomonas sp. DSMZ 13134
New
NL
Draft Assessment Report
12/12/2011
Silver thiosulfate
New
NL
Draft Assessment Report
09/01/2012
ZYMV WK
New
UK
Draft Assessment Report
09/01/2012
Candida oleophila strain O
New
UK
Draft Assessment Report
12/01/2012
Maltodextrin
New
UK
Draft Assessment Report
27/02/2012
Emamectin benzoate
New
NL
Draft Assessment Report
28/02/2012
Ipconazole
New
UK
Draft Assessment Report
08/03/2012
Pyriofenone
New
UK
Draft Assessment Report
12/03/2012
Aureobasidium pullulans
New
AT
Draft Assessment Report
27/03/2012
Amisulbrom
New
UK
Draft Assessment Report
16/04/2012
Penthiopyrad
New
UK
Draft Assessment Report
16/04/2012
Pyroxsulam
New
UK
Draft Assessment Report
01/05/2012
Spinetoram
New
UK
Draft Assessment Report
02/05/2012
Orange oil
New
FR
Draft Assessment Report
03/05/2012
Spirotetramat
New
AT
Draft Assessment Report
14/05/2012
Fluazifop-P
Post approval
FR
Assessment Report
21/05/2012
Valifenalate
New
HU
Draft Assessment Report
21/05/2012
Thiencarbazone-methyl
New
UK
Draft Assessment Report
08/06/2012
Chlorantraniliprole
New
IE
Draft Assessment Report
13/06/2012
S-abscisic acid
New
NL
Draft Assessment Report
19/06/2012
Aclonifen
Post approval
DE
Assessment Report
16/07/2012
Metribuzin
Post approval
DE
Assessment Report
16/07/2012
Clofentezine
Post approval
UK
Assessment Report
16/07/2012
Fenazaquin
Post approval
EL
Assessment Report
19/07/2012
Imidacloprid
Post approval
DE
Assessment Report
25/07/2012
Methiocarb
Post approval
UK
Assessment Report
27/07/2012
Bacillus pumilus strain QST 2808
New
NL
Draft Assessment Report
03/08/2012
Zeta-cypermethrin
Post approval
BE
Assessment Report
31/08/2012
Diflubenzuron
Post approval
SE
Assessment Report
05/09/2012
Streptomyces lydicus WYEC 108
New
NL
Draft Assessment Report
06/09/2012
Disodium phosphonates
New
FR
Draft Assessment Report
17/09/2012
Orthosulfamuron
New
IT
Draft Assessment Report
12/10/2012
Metaflumizone
New
UK
Draft Assessment Report
15/10/2012
Dichlorprop-p
Post approval
DK
Assessment Report
06/11/2012
Gamma-cyhalothrin
New
UK
Draft Assessment Report
08/11/2012
Tebuconazole
Post approval
DK
Assessment Report
04/12/2012
Ethoprophos
Post approval
UK
Assessment Report
10/01/2013
Ethametsulfuron methyl
New
UK
Draft Assessment Report
15/01/2013
Fenpyroximate
Post approval
DE
Draft Assessment Report
18/01/2013
Acrinathrin
Post approval
FR
Draft Assessment Report
18/01/2013
1,4-dimethylnaphthalene
New
NL
Draft Assessment Report
18/01/2013
Benalaxyl-M
New
PT
Draft Assessment Report
18/01/2013
Flurochloridone
Post approval
ES
Assessment Report
23/01/2013
Azadirachtin
Post approval
DE
Draft Assessment Report
08/02/2013
Tefluthrin
Post approval
DE
Assessment Report
14/02/2013
Sulfoxaflor
New
IE
Draft Assessment Report
19/02/2013
Bacillus amyloliquefaciens D747
New
DE
Draft Assessment Report
20/02/2013
Metobromuron
New
FR
Draft Assessment Report
22/02/2013
Lenacil
Post approval
BE
Assessment Report
22/03/2013
Pirimicarb
Post approval
UK
Assessment Report
04/04/2013
2,4 D
Annex I Renewal
EL
Assessment Report
19/04/2013
Flumioxazin
Annex I Renewal
CZ
Assessment Report
13/05/2013
Copper compounds
Post approval
FR
Assessment Report
13/05/2013
Amitrole
Annex I Renewal
FR
Assessment Report
16/05/2013
Benfluralin
Post approval
BE
Assessment Report
17/05/2013
Acibenzolar-S-methyl
Annex I Renewal
FR
Assessment Report
17/05/2013
Lambda-cyhalothrin
Annex I Renewal
SE
Assessment Report
23/05/2013
Cerevisane Saccharomyces cerivisiae strain LAS117
New
FR
Draft Assessment Report
24/05/2013
Epoxiconazole
Post approval
DE
Assessment Report
30/05/2013
Dimethoate
Post approval
UK
Assessment Report
03/06/2013
Bifenox
Post approval
BE
Assessment Report
04/06/2013
Beta-cypermethrin
New
UK
Draft Assessment Report
07/06/2013
Fenhexamid
Annex I Renewal
UK
Assessment Report
07/06/2013
Sulfosulfuron
Annex I Renewal
SE
Assessment Report
28/06/2013
Ferric phosphate
Annex I Renewal
DE
Assessment Report
04/07/2013
Pyridate
Annex I Renewal
AT
Assessment Report
25/07/2013
Chromafenozide
New
HU
Draft Assessment Report
13/08/2013
Prosulfuron
Annex I Renewal
FR
Assessment Report
14/08/2013
Flutianil
New
UK
Draft Assessment Report
14/08/2013
Pymetrozine
Annex I Renewal
DE
Assessment Report
06/09/2013
Thiabendazole
Annex I Renewal
ES
Assessment Report
06/09/2013
Isaria fumosorosea Apopka 97
Annex I Renewal
BE
Assessment Report
12/09/2013
Esfenvalerate
Annex I Renewal
UK
Assessment Report
24/09/2013
Myclobutanil
Post approval
BE
Assessment Report
01/10/2013
Cyantraniliprole
New
UK
Draft Assessment Report
01/10/2013
Metsulfuron-methyl
Annex I Renewal
SI
Assessment Report
03/10/2013
Terpenoid blend QRD 460
New
NL
Draft Assessment Report
10/10/2013
Iprovalicarb
Annex I Renewal
IE
Assessment Report
14/10/2013
Sulcotrione
Post approval
DE
Assessment Report
15/10/2013
Flupyrsulfuron-methyl
Annex I Renewal
FR
Assessment Report
15/10/2013
Bromuconazole
Post approval
BE
Assessment Report
22/10/2013
Haloxyfop-P
Post approval
AT
Assessment Report
04/11/2013
Metazachlor
Post approval
UK
Assessment Report
04/11/2013
Cycloxydim
Post approval
AT
Assessment Report
13/11/2013
Cyhalofop-butyl
Annex I Renewal
IT
Assessment Report
14/11/2013
Triasulfuron
Annex I Renewal
FR
Assessment Report
15/11/2013
Flumetralin
New
HU
Draft Assessment Report
02/12/2013
Pyriproxyfen
Post approval
NL
Assessment Report
09/12/2013
Indolylbutyric acid
Post approval
FR
Assessment Report
13/12/2013
Florasulam
Annex I Renewal
PL
Assessment Report
16/12/2013
Metalaxyl-M
Annex I Renewal
BE
Assessment Report
20/12/2013
Tebuconazole
Post approval
DK
Assessment Report
08/01/2014
3-decen-2-one
New
NL
Draft Assessment Report
16/01/2014
Fenoxycarb
Post approval
NL
Assessment Report
29/01/2014
Tricyclazole
New
IT
Draft Assessment Report
31/01/2014
COS-OGA
New
BE
Draft Assessment Report
03/02/2014
Sintofen
Post approval
FR
Assessment Report
03/02/2014
Pyridaben
Post approval
NL
Assessment Report
06/02/2014
Halauxifen-methyl
Annex I Renewal
UK
Draft Assessment Report
07/02/2014
Flupyradifurone
New
NL
Draft Assessment Report
13/02/2014
Pencycuron
Post approval
NL
Assessment Report
17/02/2014
8-Hydroxyquinoline
Post approval
ES
Assessment Report
19/02/2014
Oryzalin
Post approval
FR
Assessment Report
19/02/2014
Hexythiazox
Post approval
FI
Assessment Report
03/03/2014
Hymexazol
Post approval
FI
Assessment Report
03/03/2014
Metosulam
Post approval
FR
Assessment Report
03/03/2014
Clethodim
Post approval
NL
Assessment Report
03/03/2014
Isoxaben
Post approval
SE
Assessment Report
03/03/2014
Pyraflufen-ethyl
Annex I Renewal
NL
Assessment Report
05/03/2014
Glyphosate
Annex I Renewal
DE
Assessment Report
12/03/2014
Bentazone
Annex I Renewal
NL
Assessment Report
12/03/2014
Dodine
Post approval
PT
Assessment Report
12/03/2014
Mandestrobin
New
AT
Draft Assessment Report
25/03/2014
Rescalure
New
AT
Draft Assessment Report
27/03/2014
Pseudozyma flocculosa strain ATCC 64874
New
NL
Draft Assessment Report
01/04/2014
Pepino Mosaic virus, strain CH2, isolate 1906
New
BE
Draft Assessment Report
10/04/2014
Isoproturon
Annex I Renewal
DE
Assessment Report
11/04/2014
Bupirimate
Post approval
NL
Assessment Report
24/04/2014
Benzovindiflupyr
New
FR
Draft Assessment Report
07/05/2014
Clopyralid
Post approval
FI
Assessment Report
13/05/2014
Metamitron
Post approval
UK
Assessment Report
15/05/2014
Chlormequat
Post approval
UK
Assessment Report
26/05/2014
Picolinafen
Annex I Renewal
DE
Assessment Report
10/06/2014
Fluopicolide
Post approval
UK
Assessment Report
13/06/2014
Fluometuron
Post approval
EL
Assessment Report
15/07/2014
Indolylacetic acid
Existing (4th stage)
FR
Draft Assessment Report
30/07/2014
Dithianon
Post approval
EL
Assessment Report
11/08/2014
Etridiazole
Post approval
NL
Assessment Report
11/08/2014
Famoxadone
Approval renewal
UK
Assessment Report
12/08/2014
Trichoderma atroviride SC1
New
FR
Draft Assessment Report
13/08/2014
Reynoutria Sachalinensis extract
New
UK
Draft Assessment Report
13/08/2014
Thifensulfuron-methyl
Annex I Renewal
UK
Assessment Report
26/08/2014
Imazalil
Post approval
NL
Assessment Report
29/08/2014
Prothioconazole
Post approval
UK
Assessment Report
02/09/2014
Kresoxim-methyl
Post approval
BE
Assessment Report
22/09/2014
Chlorsulfuron
Post approval
FR
Assessment Report
02/03/2015


Footnote:

Existing active substances (2nd stage):
Art. 8(6) of the Commission Regulation (EC) No 451/2000 as amended by Commission Regulation (EC) No 1490/2002
Existing active substances (3rd stage):
Art. 11(3) of Commission Regulation (EC) No 1490/2002 as amended by Commission Regulation (EC) No 1095/2007
Existing active substances (4th stage):
Art. 24(5) of Commission Regulation (EC) 2229/2004 as amended by Commission Regulation (EC) No 1095/2007
Resubmissions:
Art. 9 or Art. 19(2) of Commission Regulation (EC) No 33/2008
Annex I Renewals:
Art. 11(2) of Commission Regulation (EC) No 737/2007
Art. 15(2) of Commission Regulation (EU) No 1141/2010